Omega Therapeutics, Inc.
NASDAQ: OMGA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kaan Certel
- Employees
- 93
- Headquarters
- Cambridge, United States
- IPO year
- 2021
- Market cap
- $7.9M
- Website
- https://www.omegatherapeutics.com
Loading OMGA…
Loading profile data…Frequently asked questions about OMGA
What does Omega Therapeutics, Inc. (OMGA) do?
Omega Therapeutics, Inc. functions as a biopharmaceutical firm in its development phase. Its innovative OMEGA Epigenomic Programming platform leverages epigenetics—nature's fundamental system for gene regulation and cell differentiation—to engineer therapeutic solutions. The company is advancing various omega epigenomic controller (OEC) candidat...
Where does OMGA trade?
Omega Therapeutics, Inc. (OMGA) trades on the NASDAQ Global Select.
What sector is OMGA in?
Omega Therapeutics, Inc. (OMGA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Omega Therapeutics, Inc.?
Kaan Certel is the chief executive officer of Omega Therapeutics, Inc. (OMGA).
Where is Omega Therapeutics, Inc. headquartered?
Omega Therapeutics, Inc. is headquartered in United States.
Does OMGA pay a dividend?
Omega Therapeutics, Inc. (OMGA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OMGA go public?
Omega Therapeutics, Inc. (OMGA) completed its initial public offering in 2021.